Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

  • Home
  • /
  • Ramdevbaba Solvent
Join Channel
Consolidated Standalone

Ramdevbaba Solvent

₹101.8 0 | 0%

WEBSITE BSE:0 NSE : 17 May, 00:00

Market Cap ₹225 Cr.

Stock P/E 0.0

P/B 1.9

Current Price ₹101.8

Book Value ₹ 54.5

Face Value 10

52W High ₹123.5

Dividend Yield 0%

52W Low ₹ 95.1

Edit Ratio

Ramdevbaba Solvent Research see more...

Overview Inc. Year: 2008Industry: Solvent Extraction

Ramdevbaba Solvent Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Ramdevbaba Solvent Quarterly Results

#(Fig in Cr.)
Net Sales
Other Income
Total Income
Total Expenditure
Operating Profit
Interest
Depreciation
Exceptional Income / Expenses
Profit Before Tax
Provision for Tax
Profit After Tax
Adjustments
Profit After Adjustments
Adjusted Earnings Per Share

Ramdevbaba Solvent Profit & Loss

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 105 124 115 133 187 182 199 349 416 576 687
Other Income 0 0 0 0 1 1 0 1 3 2 7
Total Income 105 124 115 133 188 183 200 350 419 579 694
Total Expenditure 101 119 110 128 181 175 190 337 403 559 669
Operating Profit 4 5 5 5 7 8 9 13 17 20 25
Interest 1 2 2 2 2 2 3 3 4 5 6
Depreciation 1 2 2 2 2 2 3 3 4 5 2
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 1 1 2 1 3 5 4 6 9 9 17
Provision for Tax 0 0 0 0 1 2 0 1 2 3 4
Profit After Tax 1 1 1 1 2 3 4 5 6 7 13
Adjustments 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 1 1 1 1 2 3 4 5 6 7 13
Adjusted Earnings Per Share 0.9 0.7 1 0.6 1.9 2.4 2.7 3.7 4.5 4.8 9.4

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 19% 25% 30% 21%
Operating Profit CAGR 25% 24% 26% 20%
PAT CAGR 86% 38% 34% 29%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR NA% NA% NA% NA%
ROE Average 31% 29% 27% 23%
ROCE Average 19% 21% 19% 17%

Ramdevbaba Solvent Balance Sheet

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 4 6 7 8 10 15 19 23 28 35 48
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 8 6 11 12 4 5 14 24 15 27 42
Other Non-Current Liabilities 0 0 -0 0 0 0 0 0 2 2 3
Total Current Liabilities 12 15 15 18 23 24 30 33 56 67 97
Total Liabilities 24 27 33 38 37 45 63 80 101 131 191
Fixed Assets 14 12 15 14 14 13 29 30 39 40 62
Other Non-Current Assets 0 0 0 0 0 11 2 1 1 13 30
Total Current Assets 10 14 17 24 23 21 32 49 61 78 99
Total Assets 24 27 33 38 37 45 63 80 101 131 191

Ramdevbaba Solvent Cash Flow

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 0 0 1 1 1 0 0 0 0 1 0
Cash Flow from Operating Activities 4 3 -2 0 7 9 3 -3 12 3 11
Cash Flow from Investing Activities -7 -1 -5 -1 -1 -11 -11 -3 -13 -18 -39
Cash Flow from Financing Activities 3 -2 6 1 -7 1 7 6 2 15 29
Net Cash Inflow / Outflow 0 1 -0 0 -0 -0 0 -0 1 -1 0
Closing Cash & Cash Equivalent 0 1 1 1 0 0 0 0 1 0 0

Ramdevbaba Solvent Ratios

# Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 0.93 0.66 1.05 0.65 1.87 2.36 2.7 3.69 4.48 4.79 9.45
CEPS(Rs) 2.66 2.58 2.54 2.37 3.44 3.48 4.92 5.87 7.54 8.54 11.1
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 4.56 5.71 6.76 7.41 9.28 11.07 13.77 16.89 20.52 25.31 34.76
Core EBITDA Margin(%) 3.41 3.78 4.02 3.79 3.14 4.05 4.56 3.43 3.13 2.94 2.67
EBIT Margin(%) 2.05 2.11 2.75 2.55 2.65 3.53 3.22 2.8 2.91 2.47 3.28
Pre Tax Margin(%) 0.9 0.88 1.33 0.75 1.61 2.66 1.86 1.8 2.03 1.58 2.45
PAT Margin (%) 0.73 0.58 0.98 0.52 1.08 1.78 1.86 1.46 1.46 1.13 1.86
Cash Profit Margin (%) 2.09 2.25 2.38 1.92 1.98 2.63 3.39 2.32 2.45 2.02 2.19
ROA(%) 4 2.83 3.79 1.97 5.38 7.99 6.88 7.1 9.63 5.67 8.08
ROE(%) 25.45 14.42 16.81 9.16 22.43 25.75 21.73 24.09 35.89 20.9 31.46
ROCE(%) 14.39 14.82 14.11 11.74 16.78 20.46 15.54 17.79 27.15 16.66 18.57
Receivable days 11.59 15.09 17.94 15.14 21.72 24.82 18.05 16.92 11.06 14.56 17.41
Inventory Days 9.5 11.81 22.29 33.18 19.2 14.06 24.62 22.02 17.43 22.46 21.48
Payable days 13.51 20.43 19.9 14.47 10.09 10.64 20.52 15.83 13.3 15.01 16.09
PER(x) 0 0 0 0 0 0 0 0 0 0 0
Price/Book(x) 0 0 0 0 0 0 0 0 0 0 0
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 0.16 0.12 0.2 0.19 0.11 0.13 0.17 0.12 0.12 0.12 0.15
EV/Core EBITDA(x) 4.56 3.07 4.76 4.9 3.23 2.97 3.53 3.37 2.94 3.54 4.11
Net Sales Growth(%) 40.39 17.95 -7.13 16.01 40.63 -2.8 9.49 75.05 236.7 38.49 19.21
EBIT Growth(%) 119.28 21.73 20.94 7.51 46.37 29.43 -0.21 52.33 371.92 16.71 59.28
PAT Growth(%) 7032.07 -6.48 57.97 -38.08 188.34 61.18 14.4 36.8 763.68 6.82 97.25
EPS Growth(%) 5086.96 -28.3 57.97 -38.08 188.36 26.04 14.4 36.8 21.39 6.82 97.25
Debt/Equity(x) 3.64 1.89 2.71 2.87 1.84 1.27 1.54 1.66 1.58 1.86 2.07
Current Ratio(x) 0.82 0.97 1.14 1.3 1 0.86 1.07 1.49 1.08 1.17 1.02
Quick Ratio(x) 0.47 0.7 0.46 0.52 0.75 0.52 0.46 0.77 0.44 0.64 0.53
Interest Cover(x) 1.79 1.71 1.93 1.42 2.54 4.04 2.38 2.81 3.31 2.77 3.93
Total Debt/Mcap(x) 0 0 0 0 0 0 0 0 0 0 0

Ramdevbaba Solvent Shareholding Pattern

#
Promoter
FII
DII
Public
Others
Total

Pros

  • Company has delivered good profit growth of 34% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 29%

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend.
  • Debtor days have increased from 15.01 to 16.09days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Ramdevbaba Solvent News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!